Developing a new quantitative imaging marker to predict pathological complete response to neoadjuvant chemotherapy

Faranak Aghaei; Alan B. Hollingsworth; Seyedehnafiseh Mirniaharikandehei; Yunzhi Wang; Hong Liu; Bin Zheng

doi:10.1117/12.2512655

13 March 2019 Developing a new quantitative imaging marker to predict pathological complete response to neoadjuvant chemotherapy

Faranak Aghaei, Alan B. Hollingsworth, Seyedehnafiseh Mirniaharikandehei, Yunzhi Wang, Hong Liu, Bin Zheng

Author Affiliations +

Proceedings Volume 10950, Medical Imaging 2019: Computer-Aided Diagnosis; 109502O (2019) https://doi.org/10.1117/12.2512655
Event: SPIE Medical Imaging, 2019, San Diego, California, United States

Abstract

Neoadjuvant (NAT) chemotherapy is a standard treatment option for many breast cancer patients. Patients who achieved pathologic complete response (pCR) after NAT, usually have better prognosis than those without. Thus, prediction of pathologic response is an important clinical issue for breast cancer patient. The purpose of this study is to develop and analyze a new computer-aided detection (CAD) and machine learning scheme using the quantitative kinetic and texture based image features extracted from breast magnetic resonance imaging (MRI) performed before and after NAT chemotherapy to predict the pCR. The images of 153 breast cancer patients underwent NAT were included in the analytical dataset. Among them, 52 achieved pCR and 101 cases were non-pCR after the NAT. A CAD scheme was developed to segment breast region and compute a total of 38 kinetic and texture features from the segmented breast regions. An image feature reduction method was used to identify 8 optimal features from the original feature pool. Then, a fine Gaussian support vector machine (FGSVM) based classifier was used to classify the two categories of pCR and non-pCR cases, which were optimized and tested using a ten-fold cross validation method. The results indicated that using features extracted from the post-chemotherapy yielded the higher area under receiver operating characteristic curves (AUC) of 0.81±0.04 and accuracy of 82% compared to using pre-chemotherapy images. This study demonstrated that image features extracted from breast MR images acquired after the NAT chemotherapy have good potential in prediction of pathology complete response.

Citation Download Citation

Faranak Aghaei, Alan B. Hollingsworth, Seyedehnafiseh Mirniaharikandehei, Yunzhi Wang, Hong Liu, and Bin Zheng "Developing a new quantitative imaging marker to predict pathological complete response to neoadjuvant chemotherapy", Proc. SPIE 10950, Medical Imaging 2019: Computer-Aided Diagnosis, 109502O (13 March 2019); https://doi.org/10.1117/12.2512655

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available